Evaluating the impact of a standardised intervention for announcing decisions of withholding and withdrawing life-sustaining treatments on the stress of relatives in emergency departments (DISCUSS): protocol for a stepped-wedge randomised controlled trial.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
05 Sep 2024
Historique:
medline: 6 9 2024
pubmed: 6 9 2024
entrez: 5 9 2024
Statut: epublish

Résumé

The decisions of withholding or withdrawing life-sustaining treatments are difficult to make in the context of emergency departments (EDs) because most patients are unable to communicate. Relatives are thus asked to participate in the decision-making process, although they are unprepared to face such situations. We therefore aimed to develop a standardised intervention for announcing decisions of withholding or withdrawing life-sustaining treatments in EDs and assess the efficacy of the intervention on the stress of relatives. The DISCUSS trial is a multicentre stepped-wedge cluster randomised study and will be conducted at nine EDs in France. A standardised intervention based on human simulation will be codesigned with partner families and implemented at three levels: the relatives, the healthcare professionals (HCP) and the EDs. The intervention will be compared with a control based on treatment as usual. A total of 538 families are planned to be included: 269 in the intervention group and 269 in the control group. The primary endpoint will be the symptoms of post-traumatic stress disorder (PTSD) at 90 days. The secondary endpoints will be symptoms of PTSD at 7 and 30 days, diagnosis of PTSD at 90 days and anxiety and depression scores at 7, 30 and 90 days. Satisfaction regarding the training, the assertiveness in communication and real-life stress of HCPs will be measured at 90 days. This study was approved by the ethics committee Est III from Nancy and the French national data protection authority. All relatives and HCPs will be informed regarding the study objectives and data confidentiality. Written informed consent will be obtained from participants, as required by French law for this study type. The results from this study will be disseminated at conferences and in a peer-reviewed journal. NCT06071078.

Identifiants

pubmed: 39237283
pii: bmjopen-2024-087444
doi: 10.1136/bmjopen-2024-087444
doi:

Banques de données

ClinicalTrials.gov
['NCT06071078']

Types de publication

Clinical Trial Protocol Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e087444

Informations de copyright

© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Anne Termoz (A)

Research on Healthcare Performance (RESHAPE), INSERM U1290, Université Claude Bernard Lyon 1-Domaine de Rockefeller, Lyon, Rhône-Alpes, France anne.termoz@chu-lyon.fr.
Pôle Santé Publique, Service Recherche et Epidémiologie Cliniques, Hospices Civils de Lyon, Lyon, Auvergne-Rhône-Alpes, France.

Fabien Subtil (F)

Pôle Santé Publique, Service de Biostatistique et Bio-informatique, Hospices Civils de Lyon, Lyon, Auvergne-Rhône-Alpes, France.
CNRS, UMR 5558, Laboratoire de Biométrie et Biologie Évolutive, Université Claude Bernard Lyon 1, Villeurbanne, Auvergne-Rhône-Alpes, France.

Pauline Drouin (P)

Pôle Santé Publique, Service Recherche et Epidémiologie Cliniques, Hospices Civils de Lyon, Lyon, Auvergne-Rhône-Alpes, France.

Mathilde Marchal (M)

Research on Healthcare Performance (RESHAPE), INSERM U1290, Université Claude Bernard Lyon 1-Domaine de Rockefeller, Lyon, Rhône-Alpes, France.
Pôle Santé Publique, Service Recherche et Epidémiologie Cliniques, Hospices Civils de Lyon, Lyon, Auvergne-Rhône-Alpes, France.

Manon Verroul (M)

Research on Healthcare Performance (RESHAPE), INSERM U1290, Université Claude Bernard Lyon 1-Domaine de Rockefeller, Lyon, Rhône-Alpes, France.
Pôle Santé Publique, Service Recherche et Epidémiologie Cliniques, Hospices Civils de Lyon, Lyon, Auvergne-Rhône-Alpes, France.

Carole Langlois (C)

Pôle Santé Publique, Service de Biostatistique et Bio-informatique, Hospices Civils de Lyon, Lyon, Auvergne-Rhône-Alpes, France.

Estelle Bravant (E)

Research on Healthcare Performance (RESHAPE), INSERM U1290, Université Claude Bernard Lyon 1-Domaine de Rockefeller, Lyon, Rhône-Alpes, France.
Pôle Santé Publique, Service Recherche et Epidémiologie Cliniques, Hospices Civils de Lyon, Lyon, Auvergne-Rhône-Alpes, France.

Laurent Jacquin (L)

Hôpital Edouard Herriot, Service d'Accueil des Urgences, Hospices Civils de Lyon, Lyon, Auvergne-Rhône-Alpes, France.

Bénédicte Clément (B)

Hôpital de la Croix-Rousse, Service d'Accueil des Urgences, Hospices Civils de Lyon, Lyon, Auvergne-Rhône-Alpes, France.

Damien Viglino (D)

Hôpital Nord, Service d'Accueil des Urgences, Centre Hospitalier Universitaire Grenoble Alpes, Grenoble, France.

Daniel Roux-Boniface (D)

Hôpital Gabriel Montpied, Service d'Accueil des Urgences, Centre Hospitalier Universitaire de Clermont-Ferrand, Clermont-Ferrand, France.

Frédéric Verbois (F)

Centre Hospitalier Nord Ouest, Service d'Accueil des Urgences, Hopital de Villefranche-sur-Saone, Villefranche-sur-Saone, Auvergne-Rhône-Alpes, France.

Marine Demarquet (M)

Centre Hospitalier Fleyriat, Service d'Accueil des Urgences, Centre Hospitalier de Bourg-en-Bresse, Bourg-en-Bresse, Rhône-Alpes, France.

Xavier Dubucs (X)

Hôpital Larrey, Service d'Accueil des Urgences, Centre Hospitalier Universitaire de Toulouse, Toulouse, Occitanie, France.

Delphine Douillet (D)

Hôpital Larrey, Service d'Accueil des Urgences, Centre Hospitalier Universitaire d'Angers, Angers, Pays de la Loire, France.

Karim Tazarourte (K)

Research on Healthcare Performance (RESHAPE), INSERM U1290, Université Claude Bernard Lyon 1-Domaine de Rockefeller, Lyon, Rhône-Alpes, France.
Hôpital Edouard Herriot, Service d'Accueil des Urgences, Hospices Civils de Lyon, Lyon, Auvergne-Rhône-Alpes, France.

Anne-Marie Schott-Pethelaz (AM)

Research on Healthcare Performance (RESHAPE), INSERM U1290, Université Claude Bernard Lyon 1-Domaine de Rockefeller, Lyon, Rhône-Alpes, France.
Pôle Santé Publique, Service Recherche et Epidémiologie Cliniques, Hospices Civils de Lyon, Lyon, Auvergne-Rhône-Alpes, France.

Julie Haesebaert (J)

Research on Healthcare Performance (RESHAPE), INSERM U1290, Université Claude Bernard Lyon 1-Domaine de Rockefeller, Lyon, Rhône-Alpes, France.
Pôle Santé Publique, Service Recherche et Epidémiologie Cliniques, Hospices Civils de Lyon, Lyon, Auvergne-Rhône-Alpes, France.

Marion Douplat (M)

Research on Healthcare Performance (RESHAPE), INSERM U1290, Université Claude Bernard Lyon 1-Domaine de Rockefeller, Lyon, Rhône-Alpes, France.
Hôpital Lyon Sud, Service d'Accueil des Urgences, Hospices Civils de Lyon, Lyon, Auvergne-Rhône-Alpes, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH